Codexis, Inc. (CDXS) Social Stream

Codexis, Inc. (CDXS)

Today's Latest Price: $17.90 USD

0.52 (2.99%)

Updated Nov 24 4:00pm

Add CDXS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Featured Post From StockTwits About CDXS

$CDXS The tone of the conference call was decidedly positive. Their product revenue will be at the high end of guidance and possibly as good as last year, despite a pandemic. Januvia is still the leader in product revenue. Not sure how long before it goes off patent. Starting to see product revenue come in from Tate and Lyle for Tasteva M. Should continue to increase next year. Still anticipating as much as $10 million a year or more from that product alone, but it could take 3 to 5 years to reach that.
Lots of information about DNA and RNA polymerase products. Lots of interest from multiple companies. Definitely looking to include this into Covid vaccine production at some point.
DJGustave, published November 24, 2020

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.873 seconds.